General Information
Version
6.8
Revision date
2025-02-05
Product name
Sodium pyruvate, anhydrous, free-flowing, Redi-Dri(TM), ReagentPlus(R), >=99%
CAS No.
113-24-6
REACH No
01-2120767047-50-XXXX
Emergency telephone
+33 (0)9 75 18 14 07, +33 (0)1 45 42 59 59
Icons in SDS
Company Information
company name
Merck Life Science S.A.S
e-mail address of the competent person responsible for the Safety Data Sheet
servicetechnique@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H319
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture Eye irritation, (Category 2) H319: Causes serious eye irritation Skin sensitization, (Sub-category H317: May cause an allergic skin reaction 1B)
Signal word
Warning Warning
Hazard statements
H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. Reduced Labeling (<= 125 ml) H317 May cause an allergic skin reaction.
Precautionary statements
P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of water.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Eye irritation, (Category 2) H319: Causes serious eye irritation. Skin sensitization, (Sub-category H317: May cause an allergic skin reaction. 1B)